Literature DB >> 18256154

Recombinant VP4 of human rhinovirus induces permeability in model membranes.

Matthew P Davis1, Graham Bottley, Lucy P Beales, Richard A Killington, David J Rowlands, Tobias J Tuthill.   

Abstract

In common with all nonenveloped viruses, the mechanism of picornavirus membrane penetration during cell entry is poorly understood. The small, myristylated capsid protein VP4 has been implicated in this process. Here we show that recombinant VP4 of human rhinovirus 16 has the ability to associate with and induce membrane permeability in otherwise intact liposomes. This provides further evidence that VP4 plays a key role in picornavirus cell entry.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256154      PMCID: PMC2293005          DOI: 10.1128/JVI.01070-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.

Authors:  C E Fricks; J M Hogle
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Pore formation induced by the peptide melittin in different lipid vesicle membranes.

Authors:  S Rex
Journal:  Biophys Chem       Date:  1996-01-16       Impact factor: 2.352

3.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

4.  Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1.

Authors:  J M Greve; C P Forte; C W Marlor; A M Meyer; H Hoover-Litty; D Wunderlich; A McClelland
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Uncoating of human rhinovirus serotype 2 from late endosomes.

Authors:  E Prchla; E Kuechler; D Blaas; R Fuchs
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion.

Authors:  H Hoover-Litty; J M Greve
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

7.  The major and minor group receptor families contain all but one human rhinovirus serotype.

Authors:  C R Uncapher; C M DeWitt; R J Colonno
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

8.  The structure of human rhinovirus 16.

Authors:  M A Oliveira; R Zhao; W M Lee; M J Kremer; I Minor; R R Rueckert; G D Diana; D C Pevear; F J Dutko; M A McKinlay
Journal:  Structure       Date:  1993-09-15       Impact factor: 5.006

9.  Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group.

Authors:  W M Lee; W Wang; R R Rueckert
Journal:  Virus Genes       Date:  1995-01       Impact factor: 2.332

10.  Virus-mediated release of endosomal content in vitro: different behavior of adenovirus and rhinovirus serotype 2.

Authors:  E Prchla; C Plank; E Wagner; D Blaas; R Fuchs
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

View more
  24 in total

1.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

2.  The VP4 peptide of hepatitis A virus ruptures membranes through formation of discrete pores.

Authors:  Ashutosh Shukla; Aditya K Padhi; James Gomes; Manidipa Banerjee
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

3.  Toll-like receptor 2-expressing macrophages are required and sufficient for rhinovirus-induced airway inflammation.

Authors:  Mingyuan Han; Yutein Chung; Jun Young Hong; Charu Rajput; Jing Lei; Joanna L Hinde; Qiang Chen; Steven P Weng; J Kelley Bentley; Marc B Hershenson
Journal:  J Allergy Clin Immunol       Date:  2016-04-12       Impact factor: 10.793

4.  A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid resistance.

Authors:  Miguel A Martín-Acebes; Angela Vázquez-Calvo; Verónica Rincón; Mauricio G Mateu; Francisco Sobrino
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

5.  Myristoylated rhinovirus VP4 protein activates TLR2-dependent proinflammatory gene expression.

Authors:  J Kelley Bentley; Mingyuan Han; Suraj Jaipalli; Joanna L Hinde; Jing Lei; Tomoko Ishikawa; Adam M Goldsmith; Charu Rajput; Marc B Hershenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-25       Impact factor: 5.464

6.  Cryo-EM study of slow bee paralysis virus at low pH reveals iflavirus genome release mechanism.

Authors:  Sergei Kalynych; Tibor Füzik; Antonín Přidal; Joachim de Miranda; Pavel Plevka
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-04       Impact factor: 11.205

7.  A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition.

Authors:  Miguel A Martín-Acebes; Verónica Rincón; Rosario Armas-Portela; Mauricio G Mateu; Francisco Sobrino
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

8.  Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner.

Authors:  Stewart Goodwin; Tobias J Tuthill; Armando Arias; Richard A Killington; David J Rowlands
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

9.  Low pH-triggered beta-propeller switch of the low-density lipoprotein receptor assists rhinovirus infection.

Authors:  Tuende Konecsni; Ursula Berka; Angela Pickl-Herk; Gerhard Bilek; Abdul Ghafoor Khan; Leszek Gajdzig; Renate Fuchs; Dieter Blaas
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

10.  Myristoylation of EV71 VP4 is Essential for Infectivity and Interaction with Membrane Structure.

Authors:  Jiaming Cao; Meng Qu; Hongtao Liu; Xuan Wan; Fang Li; Ali Hou; Yan Zhou; Bo Sun; Linjun Cai; Weiheng Su; Chunlai Jiang
Journal:  Virol Sin       Date:  2020-05-12       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.